Literature DB >> 15952718

Comparative analysis of the tear protein expression in blepharitis patients using two-dimensional electrophoresis.

Bon-Suk Koo1, Do-Yeon Lee, Hyo-Shin Ha, Jae-Chan Kim, Chan-Wha Kim.   

Abstract

Change in the expression of body fluid proteins is caused by many diseases or environmental disturbances. The changes in tear proteins are also associated with various pathological eye conditions. Especially, chronic blepharitis is one of the most common conditions seen in the ophthalmologist's office. However, there are no specific clinical diagnostic tests for blepharitis, and it is difficult to treat effectively. Therefore, the aim of this study was to screen prognostic or diagnostic marker tear proteins for blepharitis and investigate pathogenesis of this disease using proteomics techniques. The tear proteins expressed in patients suffering from blepharitis (patient, n=19) and healthy volunteers (control, n=27) were analyzed using the two-dimensional electrophoresis (2-DE) technique. The differentially expressed proteins in patients were identified with ESI-Q-TOF (electrospray-quadrupole-time-of-flight) mass spectrometry and confirmed with western blotting. Nine proteins in patient were down regulated about 50% compared to those of the control: serum albumin precursor, alpha-1 antitrypsin, lacritin precursor, lysozyme, Ig-kappa chain VIII, prolactin inducible protein (PIP/GCDFP-15), cystatin-SA III, pyruvate kinase, and an unnamed protein. The use of the two-dimensional eletrophoretic technique could give more insight into the disease-related protein expression changes in tear fluids. Our findings reveal that the composition of tear proteins in blepharitis patients is different from that of healthy subjects and may provide further insights into the pathogenesis of blepharitis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15952718     DOI: 10.1021/pr0498133

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  38 in total

Review 1.  Lacritin and other autophagy associated proteins in ocular surface health.

Authors:  Roy Karnati; Venu Talla; Katherine Peterson; Gordon W Laurie
Journal:  Exp Eye Res       Date:  2015-08-25       Impact factor: 3.467

2.  Dry eye and designer ophthalmics.

Authors:  Gordon W Laurie; Leslie A Olsakovsky; Brian P Conway; Robert L McKown; Kazuko Kitagawa; Jason J Nichols
Journal:  Optom Vis Sci       Date:  2008-08       Impact factor: 1.973

Review 3.  Lacritin and the tear proteome as natural replacement therapy for dry eye.

Authors:  Roy Karnati; Diane E Laurie; Gordon W Laurie
Journal:  Exp Eye Res       Date:  2013-06-12       Impact factor: 3.467

4.  Detection of prosecretory mitogen lacritin in nonprimate tears primarily as a C-terminal-like fragment.

Authors:  Diane E Laurie; Rebecca K Splan; Kari Green; Katherine M Still; Robert L McKown; Gordon W Laurie
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-12       Impact factor: 4.799

Review 5.  TFOS DEWS II Tear Film Report.

Authors:  Mark D P Willcox; Pablo Argüeso; Georgi A Georgiev; Juha M Holopainen; Gordon W Laurie; Tom J Millar; Eric B Papas; Jannick P Rolland; Tannin A Schmidt; Ulrike Stahl; Tatiana Suarez; Lakshman N Subbaraman; Omür Ö Uçakhan; Lyndon Jones
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

6.  iTRAQ quantitative proteomics in the analysis of tears in dry eye patients.

Authors:  Sruthi Srinivasan; Mirunalni Thangavelu; Liwen Zhang; Kari B Green; Kelly K Nichols
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-31       Impact factor: 4.799

7.  A cleavage-potentiated fragment of tear lacritin is bactericidal.

Authors:  Robert L McKown; Erin V Coleman Frazier; Kaneil K Zadrozny; Andrea M Deleault; Ronald W Raab; Denise S Ryan; Rose K Sia; Jae K Lee; Gordon W Laurie
Journal:  J Biol Chem       Date:  2014-06-18       Impact factor: 5.157

8.  PRR4: A novel downregulated gene in laryngeal cancer.

Authors:  Seda Ekizoglu; Turgut Ulutin; Jalal Guliyev; Nur Buyru
Journal:  Oncol Lett       Date:  2018-01-29       Impact factor: 2.967

9.  Tissue transglutaminase is a negative regulator of monomeric lacritin bioactivity.

Authors:  Francisco Velez V; Jeffrey A Romano; Robert L McKown; Kari Green; Liwen Zhang; Ronald W Raab; Denise S Ryan; Cindy M L Hutnik; Henry F Frierson; Gordon W Laurie
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-01       Impact factor: 4.799

10.  Lacritin-induced secretion of tear proteins from cultured monkey lacrimal acinar cells.

Authors:  Atsuko Fujii; Ayumi Morimoto-Tochigi; Ryan D Walkup; Thomas R Shearer; Mitsuyoshi Azuma
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-05       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.